Cholesterol-depleting drugs for HER2-targeted radioimmunotherapy of patient-derived esophagogastric (EG) cancer Meeting Abstract


Authors: Rao, Y.; Pereira, P.; Samuels, Z.; Lewis, J.
Abstract Title: Cholesterol-depleting drugs for HER2-targeted radioimmunotherapy of patient-derived esophagogastric (EG) cancer
Meeting Title: International Symposium on Radiopharmaceutical Sciences (iSRS 2022)
Journal Title: Nuclear Medicine and Biology
Volume: 108-109
Issue: Suppl.
Meeting Dates: 2022 May 29-Jun2
Meeting Location: Nantes, France
ISSN: 0969-8051
Publisher: Elsevier Science Inc.  
Date Published: 2022-05-01
Start Page: S210
End Page: S211
Language: English
ACCESSION: WOS:000802721400378
PROVIDER: wos
DOI: 10.1016/S0969-8051(22)00432-2
Notes: Meeting Abstract: P296 -- Listed under section named "Poster Presentations: Applications of radiolabeled compounds in oncology" -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jason S Lewis
    456 Lewis
  2. Yi Rao
    6 Rao
  3. Zachary Samuels
    17 Samuels